1. Amawi, H, Abu Deiab, GI, Aljabali, AA, Dua, K, Tambuwala M, M. COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics. Ther Delivery. 2020;11(4):245–268.
Google Scholar | Crossref | Medline2. Cucinotta, D, Vanelli, M. WHO Declares COVID-19 a pandemic. Acta Biomedica. 2020;91(1):157–160.
Google Scholar | Medline3. Yazdani, R, Habibi, S, Sharifi, L, et al. Common variable immunodeficiency: epidemiology, pathogenesis, clinical manifestations, diagnosis, classification, and management. Journal of Investigational Allergology Clinical Immunology. 2020;30(1):14–34.
Google Scholar | Crossref | Medline4. Cohen, B, Rubinstein, R, Gans, M, Deng, L, Rubinstein, A, Eisenberg, R. COVID-19 infection in 10 common variable immunodeficiency patients in New York city. J Allergy Clin Immunol. 2021;9(1):504–507.
Google Scholar | Crossref5. Murphy, K, Weaver, C. Janeway immunology. 9th ed. Garland Science; 2016.
Google Scholar | Crossref6. Rabadi, T, Brady, MF. Tetanus toxoid. In: StatPearls [Internet]. StatPearls Publishing; 2021.
Google Scholar7. Oliver, S, Gargano, J, Marin, M, et al. The advisory committee on immunization Practices’ interim recommendation for Use of pfizer-BioNTech COVID-19 vaccine — United States, December 2020. Morb Mortal Wkly Rep 2020;69(50):1922–1924.
Google Scholar | Crossref | Medline8. Zhao, J, Zhao, S, Ou, J, et al. COVID-19: coronavirus vaccine development updates. Front Immunol. 2020;11:1–19.
Google Scholar | Crossref | Medline9. Sahin, U, Muik, A, Vogler, I, et al. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature. 2021;595(7868):572–577.
Google Scholar | Crossref | Medline